UK company Reaxa is spinning out a new company called ADC Biotechnology to develop and commercialise an improved purification technology …
Catalyst specialist Reaxa will lead a consortium, backed by more than £700,000 ($1.1 million) in UK government funding, to develop …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

